Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 1447 | 9005-80-5 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
A starch found in the tubers and roots of many plants. Since it is hydrolyzable to FRUCTOSE, it is classified as a fructosan. It has been used in physiologic investigation for determination of the rate of glomerular function.
|
None
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Aug. 25, 2021 | PMDA | FUJI YAKUHIN Co., Ltd | |
| April 30, 1940 | FDA | ISO TEX |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | V04CH01 | VARIOUS DIAGNOSTIC AGENTS OTHER DIAGNOSTIC AGENTS Tests for renal function and ureteral injuries |
| CHEBI has role | CHEBI:55323 | antidiarrhoeal drug |
| CHEBI has role | CHEBI:74518 | anti-obesity agent |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Renal function study | indication | 44277000 | |
| Constipation | contraindication | 14760008 | DOID:2089 |
| Hyperphosphatemia | contraindication | 20165001 | DOID:0050459 |
| Hypervitaminosis D | contraindication | 27712000 | DOID:9971 |
| Sarcoidosis | contraindication | 31541009 | DOID:11335 |
| Dehydration | contraindication | 34095006 | |
| Hypercalcemia | contraindication | 66931009 | DOID:12678 |
| Hyperparathyroidism | contraindication | 66999008 | DOID:13543 |
| Kidney disease | contraindication | 90708001 | DOID:557 |
| Kidney stone | contraindication | 95570007 | |
| Osteolysis | contraindication | 203522001 | |
| Arteriosclerosis obliterans | contraindication | 361133006 | DOID:5160 |
None
None
None
None
None
None
| ID | Source |
|---|---|
| 4018838 | VUID |
| N0000147140 | NUI |
| D00171 | KEGG_DRUG |
| 4018838 | VANDF |
| C0021936 | UMLSCUI |
| CHEBI:15443 | CHEBI |
| CHEMBL1201646 | ChEMBL_ID |
| DB00638 | DRUGBANK_ID |
| JOS53KRJ01 | UNII |
| 5924 | RXNORM |
| 17140 | MMSL |
| d04848 | MMSL |
| 002342 | NDDF |
| D007444 | MESH_DESCRIPTOR_UI |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| JBA Verestor Mega Fiber Powder | HUMAN OTC DRUG LABEL | 8 | 13411-862 | POWDER | 1500 mg | ORAL | unapproved drug other | 6 sections |
| JBA Verestor Mega Fiber Caffe Latte | HUMAN OTC DRUG LABEL | 5 | 13411-863 | POWDER | 1000 mg | ORAL | unapproved drug other | 6 sections |
| Livita Adults | HUMAN PRESCRIPTION DRUG LABEL | 17 | 59088-659 | LIQUID | 500 mg | ORAL | unapproved drug other | 10 sections |
| Livita Children | HUMAN PRESCRIPTION DRUG LABEL | 17 | 59088-660 | LIQUID | 166.67 mg | ORAL | unapproved drug other | 10 sections |